Related Experiment Videos
Living with chronic hepatitis
Insights
Chronic hepatitis in children involves distinct immune responses. Autoimmune CH is steroid-responsive, while Hepatitis B virus (HBV) and Hepatitis delta virus (HDV) infections have varied prognoses and treatments.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Immunology
Background:
- Chronic hepatitis (CH) is defined as persistent liver inflammation (>4 months).
- CH in children involves diverse immune mechanisms leading to liver damage.
- Understanding these mechanisms is crucial for diagnosis and prognosis.
Purpose of the Study:
- To differentiate immune mechanisms in common types of pediatric CH.
- To correlate immune responses with clinical outcomes and treatment responses.
- To provide a basis for understanding CH in children.
Main Methods:
- Analysis of immune cell involvement (T cells, non-T cells, lymphocytes) in liver damage.
- Categorization of CH based on causative agents: autoimmune, Hepatitis B virus (HBV), Hepatitis delta virus (HDV), and Non-A, Non-B (NANB).
- Correlation of immune profiles with clinical presentation, prognosis, and treatment responsiveness.
Main Results:
- Autoimmune CH: Primarily non-T cell mediated, steroid-responsive, favorable prognosis.
- HBV hepatitis: Both T and non-T lymphocytes involved; treatment controversial, less favorable prognosis.
- HDV hepatitis (superinfection): Rapidly progressive, serious prognosis.
- NANB hepatitis: Predominantly T cell mediated, mild course, no treatment typically recommended.
Conclusions:
- Pediatric CH exhibits distinct immunopathological profiles based on etiology.
- Immune mechanisms directly influence disease severity, prognosis, and treatment strategies.
- Differentiating CH types is essential for effective management in children.
Abstract:
Chronic hepatitis (CH) may be defined as persistence of an inflammatory reaction in the liver for greater than 4 months. Different immune mechanisms of liver damage are operative in children with the three common types of CH. In autoimmune CH the cytotoxic effect is mostly confined to the non-T cell lymphocyte fraction. Autoimmune CH is steroid responsive and has a generally favorable prognosis. In hepatitis B virus (HBV) hepatitis both T and non-T lymphocytes are responsible for the cytotoxic reaction. Steroid or interferon treatment is controversial and the prognosis is less favorable. Hepatitis delta virus (HDV) hepatitis only occurs in children with HBV hepatitis as either a co-infection or superinfection. As a co-infection the HBV is usually eliminated and CH does not ensue. Superinfection with HDV, however, frequently leads to rapidly progressive liver damage and a more serious prognosis. Non-A, non-B (NANB) hepatitis is a diagnosis of exclusion. In NANB hepatitis, the cytotoxic effect is predominantly T cell. NANB hepatitis generally runs a mild course, and no treatment is usually recommended.